Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02441985 · ClinicalTrials.gov registry record · NA
rTMS Therapy for Primary Orthostatic Tremor
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02441985 is a NA study that has completed, run by University of Florida. The registered enrollment target is 10 participants.
The verdict
NCT02441985, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Primary orthostatic tremor(POT) is a rare progressive functionally disabling tremor disorder. The characteristic features of POT are symptoms of unsteadiness in legs reported by patients when they are standing and improvement of symptoms upon walking and sitting. Due to the limited success of other treatment options there is a clear merit in continuing efforts to explore and investigate novel treatment modalities. Transcranial magnetic stimulation (TMS) is a well-established physiological tool to understand brain function. When repetitious TMS pulses are delivered to a specific target at predefined stimulation parameters, it is referred to as rTMS therapy.The investigators propose a novel approach to investigate the clinical and physiological effects of low frequency rTMS therapy in POT. The overarching hypothesis of this study is that low frequency rTMS therapy delivered to the cerebellum will modulate the cerebellar excitability and result in clinical improvements.In order to determine the physiological effects related to rTMS, the tremor physiology will also be recorded with surface electromyography (EMG). The investigator will also record the changes in cerebellum excitability in response to rTMS using cerebello-cortical inhibition (CBI), a well-established TMS parameter.
Interventions
- DEVICE Magstim RapidStim2
- DEVICE Sham Magstim RapidStim2
- OTHER Fullerton Advanced Balance (FAB) Scale
- OTHER Timed "Up & Go" Test (TUG) test
- OTHER 10m walk test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-01-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02441985
The ClinicalTrials.gov registry entry for NCT02441985 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Magstim RapidStim2 is the first listed.
NCT02441985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02441985 about?
NCT02441985 is a clinical study titled "rTMS Therapy for Primary Orthostatic Tremor". Primary orthostatic tremor(POT) is a rare progressive functionally disabling tremor disorder. The characteristic features of POT are symptoms of unsteadiness in legs reported by patients when they are standing and improvement of symptoms upon walking and sitting. Due to the limited success of other ...
What is the current status of trial NCT02441985?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2015-08. Estimated completion is 2019-01-08.
What interventions are being tested in trial NCT02441985?
The interventions under investigation include: Magstim RapidStim2 (DEVICE), Sham Magstim RapidStim2 (DEVICE), Fullerton Advanced Balance (FAB) Scale (OTHER), Timed "Up & Go" Test (TUG) test (OTHER), 10m walk test (OTHER).
Who is sponsoring clinical trial NCT02441985?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.